Finance
Activist investor Elliott builds LSEG stake to push for change, source says
Feb 11 (Reuters) - Activist hedge fund Elliott Management has built a significant stake in the Londo...
11th February, 2026
equity
Finance
ABN Amro misses fourth-quarter profit expectations
Feb 11 (Reuters) - ABN Amro plans to share an additional 500 million euros ($595 million) with its s...
11th February, 2026
Finance
Analysis-China tightens market oversight to create 'slow bull' momentum
SHANGHAI/HONG KONG, Feb 11 (Reuters) - As global capital trickles back toward China, policymakers ar...
10th February, 2026
Finance
Factbox-By the numbers: How the Netflix, Paramount bids for Warner Bros stack up
Feb 10 (Reuters) - Paramount Skydance sweetened its bid for Warner Bros Discovery on Tuesday by offe...
10th February, 2026
Finance
Vatican bank teams with Morningstar on Catholic stock indexes
VATICAN CITY, Feb 10 (Reuters) - The Vatican bank has joined with Morningstar to launch two new equi...
10th February, 2026
Finance
Italy's MPS seeks maximum savings in revamp post-Mediobanca deal
MILAN, Feb 10 (Reuters) - Italy's Monte dei Paschi di Siena on Tuesday posted a 1.35-billion-euro ($...
10th February, 2026
Finance
Barclays lifts profit and targets as it looks to US to boost returns
LONDON, Feb 10 (Reuters) - Barclays said its annual profit increased 12% on Tuesday, as it announced...
10th February, 2026
Finance
Stocks mixed but world index hits record high; Treasury yields fall
By Gregor Stuart Hunter SINGAPORE, Feb 10 (Reuters) - Asian stocks advanced for a second day in earl...
10th February, 2026
Finance
Odido shelves IPO plans because of muted investor response and volatility, sources say
By Charlie Conchie LONDON, Feb 9 (Reuters) - Dutch telecoms company Odido has postponed plans for an...
9th February, 2026
Finance
Morning Bid: Japan markets welcome chance of a long-stay PM
A look at the day ahead in European and global markets from Wayne Cole. So, something political mark...
9th February, 2026
Finance
Analysis-Investors chase cheaper, smaller companies as risk aversion hits tech sector
By Suzanne McGee Feb 8 (Reuters) - Investors are turning to cheaper, smaller companies while reasses...
8th February, 2026
Finance
Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
Feb 6 (Reuters) - Shares of Agomab Therapeutics fell about 8% in their Nasdaq debut on Friday, valui...
6th February, 2026